Clarithromycin | Interleukin Related interleukin-related.com

Product Name :
Clarithromycin

Search keywords :
Clarithromycin

drugId :
null

Target Vo:
50S ribosomal subunit

Target Vo Short Name :
50S ribosomal subunit

Moa_Name:
50S ribosomal subunit inhibitors

First Approval Country :
Japan

First Approval Date Filter:
1991

Origin Company_Name :
Taisho Pharmaceutical Holdings Co Ltd

Active Company_Name :
Emory University

Active Indication_Name:
Sinusitis

In Active Indication_Name:
HIV Infections

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FXR1 Antibody site
Benralizumab Cancer
Cyclophilin B Antibody (YA787): Cyclophilin B Antibody (YA787) is a non-conjugated and Mouse origined monoclonal antibody about 24 kDa, targeting to Cyclophilin B (5F10). It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat, Mouse.

Author: Interleukin Related

Related Posts